lilly direct compounded tirzepatide FDA will reconsider decision barring copycat versions of weight loss drug Lilly Tirzepatide: Portfolio and Context

Lilly Agreement With Trump Administration Reshapes Patient Access to GLP-1 Obesity Medicines Nicholas Jacobus Key Takeaways Eli Lilly collaborates with the Trump administration to improve access to GLP-1 receptor agonists for millions of Americans, including those on government programs

The computation of the Nutri-Score is evolving to provide better recommendations based on the latest scientific evidence

Some researchers exploring tesofensine for weight management are interested in compounds that provide mild stimulant effects alongside appetite suppression, though the long-term safety profile of such approaches remains under investigation

Reproductive health research reveals significant applications in studying age-related endocrine dysfunction, with laboratory studies showing that FOXO4-DRI improves the testicular microenvironment and alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged male mice